European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn:
“First Patient In for RENALUT!
We are pleased to share that the first patient has now been enrolled in the EORTC 2361 RENALUT trial at Centre François Baclesse, France, by Prof. Florence Joly.
This First Patient In milestone marks an important step forward for the study led by Study Coordinators Prof. Emmanuel Seront (Cliniques universitaires Saint-Luc, Belgium), Prof Laurence Albiges (Gustave Roussy, France), Prof Karolien Goffin (UZ Leuven, Belgium), Prof Bertrand Tombal (Cliniques universitaires Saint‑Luc, Belgium) and reflects the strong collaboration between investigators, study teams, and the EORTC Genito‑Urinary Cancer Group.
Congratulations to everyone involved in reaching this key starting point of the trial.”
Other articles about RENALUT on OncoDaily.